Epidemiological study air disaster in Amsterdam (ESADA): Study design

BMC Public Health

Volumn 5, Issue , 2005, Pages

  Slottje, Pauline ^a   Huizink, Anja C ^a,b   Twisk, Jos W R ^a   Witteveen, Anke B ^a   Van Der Ploeg, Henk M ^a   Bramsen, Inge ^a   Smidt, Nynke ^a   Bijlsma, Joost A ^a   Bouter, Lex M ^a   Van Mechelen, Willem ^a   Smid, Tjabe ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c KLM Health Services   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AIRCRAFT; AIRCRAFT ACCIDENT; ARTICLE; BLOOD EXAMINATION; DISASTER; EPIDEMIOLOGICAL DATA; FEMALE; FIRE FIGHTER; HEALTH; HUMAN; LABORATORY TEST; MALE; NETHERLANDS; OCCUPATIONAL EXPOSURE; POLICE; QUALITY OF LIFE; QUESTIONNAIRE; SALIVA ANALYSIS; SELF REPORT; SYMPTOM; TASK PERFORMANCE; URINALYSIS; WORKER; ADULT; ANALYSIS; AVIATION; DANGEROUS GOODS; EPIDEMIOLOGY; FIRE; MANPOWER; MIDDLE AGED; MORTALITY; OCCUPATIONAL HEALTH; PREVENTION AND CONTROL; PSYCHOLOGY; RECALL; RESCUE WORK; SELF CONCEPT; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC; TIME;

DANGEROUS GOODS;

ACCIDENTS, AVIATION; ADULT; AVIATION; DISASTERS; EPIDEMIOLOGIC STUDIES; FEMALE; FIRES; HAZARDOUS SUBSTANCES; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NETHERLANDS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; POLICE; QUALITY OF LIFE; RESCUE WORK; SELF CONCEPT; STRESS DISORDERS, POST-TRAUMATIC; TIME;

EID: 23044483341     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-5-54     Document Type: Article

References (77)

1. Meijer ThAM: Een Beladen Vlucht. Eindrapport Bijlmer Enquete. [Final Report on the Parliamentary Enquiry Air Disaster in Amsterdam] 's-Gravenhage: Sdu Uitgevers; 1999.
2. Boin A, Duin van M, Heyse L: Toxic fear: the management of certainty in the wake of the Amsterdam air crash. J Hazard Mater 2001, 88:213-34.
3. Yzermans CJ, Gersons BPR: The Chaotic Aftermath of an Airplane Crash in Amsterdam: A Second Disaster. In Toxic turmoil. Psychological and Societal Consequences of Ecological Disasters Edited by: Havenaar JM, Cwickel JG, Bromet EJ. New York: Kluwer Academic/ Plenum Publishers; 2002:85-98.
4. Vasterman P, IJzermans J: Ziek van de ramp of van het nieuws óver de ramp? [Ilness due to the disaster itself or due to the news about the disaster?]. Tijdschr Mediageschiedenis 2002, 5:89-109.
5. Uijt de Haag PA, Smetsers RC, Witlox HW, Eisenga AH: Evaluating the risk from depleted uranium after the Boeing 747-258F crash in Amsterdam, 1992. J Hazard Mater 2000, 76:39-58.
6. Donker GA, Yzermans CJ, Spreeuwenberg P, Van der Zee J: Symptom attribution after a plane crash: comparison between self-reported symptoms and GP records. Br J Gen Pract 2002, 52:917-22.
7. Leon GR: Overview of the psychosocial impact of disasters. Prehospital Disaster Med 2004, 19:4-9.
8. Clauw DJ, Engel CC Jr, Aronowitz R, Jones E, Kipen HM, Kroenke K, Ratzan S, Sharpe M, Wessely S: Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med 2003, 45:1040-8.
9. Jones E, Hodgins-Vermaas R, McCartney H, Everitt B, Beech C, Poynter D, Palmer I, Hyams K, Wessely S: Post-combat syndromes from the Boer war to the Gulf war: a cluster analysis of their nature and attribution. BMJ 2002, 324:321-4.
10. Koscheyev VS, Leon GR, Gourine AV, Gourine VN: The psychosocial aftermath of the Chernobyl disaster in an area of relatively low contamination. Prehospital Disaster Med 1997, 12:41-6.
11. Havenaar J, Rumyantzeva G, Kasyanenko A, Kaasjager K, Westermann A, Van den Brink W, Savelkoul J: Health effects of the Chernobyl disaster: illness or illness behavior? A comparative general health survey in two former Soviet regions. Environ Health Perspect 1997, 105:1533-7.
12. Collins DL, de Carvalho AB: Chronic stress from the Goiania 137Cs radiation accident. Behav Med 1993, 18:149-57.
13. Katz CL, Pellegrino L, Pandya A, Ng A, DeLisi LE: Research on psychiatric outcomes and interventions subsequent to disasters: a review of the literature. Psychiatry Res 2002, 110:201-17.
14. Norris FH, Friedman MJ, Watson PJ, Byme CM, Diaz E, Kaniasty K: 60,000 disaster victims speak: Part I. An empirical review of the empirical literature, 1981-2001. Psychiatry 2002, 65:207-39.
15. Bromet E, Dew MA: Review of psychiatric epidemiologic research on disasters. Epidemiol Rev 1995, 17:113-9.
16. Nasralla M, Haier J, Nicolson GL: Multiple Mycoplasmal Infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999, 18:859-65.
17. Vojdani A, Choppa PC, Tagle C, Andrin R, Samimi B, Lapp CW: Detection of Mycoplasma genus and mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998, 22:355-65.
18. Nicolson GL, Gan R, Haier J: Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS 2003, 111:557-66.
19. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K: High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 2002, 34:209-14.
20. Endresen GK: Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes. Rheumatol Int 2003, 23:211-5.
21. Collins JF, Donta ST, Engel CC, Baseman JB, Dever LL, Taylor T, Boardman KD, Martin SE, Wiseman AL, Feussner JR: The antibiotic treatment trial of Gulf War Veterans' Illnesses: issues, design, screening, and baseline characteristics. Control Clin Trials 2002, 23:333-53.
22. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T: Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994, 18:S62-7.
23. Kuratsune H, Yamaguti K, Lindh G, Evengard B, Takahashi M, Machii T, Matsumura K, Takaishi J, Kawata S, Langstrom B, Kanakura Y, Kitani T, Watanabe Y: Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med 1998, 2:51-6.
24. Plioplys AV, Plioplys S: Serum levels of carnitine in chronic fatigue a syndrome: clinical correlates. Neuropsychobiology 1995, 32:132-8.
25. Plioplys AV, Plioplys S: Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 1997, 35:16-23.
26. Vermeulen RC, Scholte HR: Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med 2004, 66:276-82.
27. Komaroff AL, Bell DS, Cheney PR, Lo SC: Absence of antibody to Mycoplasma fermentans in patients with chronic fatigue syndrome. Clin Infect Dis 1993, 17:1074-5.
28. Vernon SD, Shukla SK, Reeves WC: Absence of Mycoplasma species DNA in chronic fatigue syndrome. J Med Microbiol 2003, 52:1027-8.
29. Soetekouw PM, Wevers RA, Vreken P, Elving LD, Janssen AJ, Veen van der Y, Bleijenberg G, Meer van der JW: Normal carnitine levels in patients with chronic fatigue syndrome. Neth J Med 2000, 57:20-4.
30. ESADA Website [http://www.movb.nl/en/index.htm]
31. APA: Diagnostic and statistical manual of mental disorders-IV-TR. Washington, D.C 2000.
32. Hovens JE, Ploeg van der HM, Bramsen I, Klaarenbeek MTA, Schreuder JN, Rivero VV: The development of a Dutch Self-rating Inventory for Posttraumatic Stress Disorder. Acta Psychiatr Scand 1994, 90:172-83.
33. Hovens JE, Bramsen I, Ploeg van der HM: Zelfinventarisatielijst Posttraumatische Stress stoornis (ZIL). Handleiding. [Self-Rating Inventory for Posttraumatic stress disorder (PTSD). Manual] Lisse: Swets Test Publishers; 2000.
34. Hovens JE, Ploeg van der HM, Bramsen I, Reuling I: Test-retest reliability of the Self-rating Inventory for PTSD. Psychol Rep 2000, 87:735-7.
35. Joseph S: Psychometric Evaluation of Horowitz's Impact of Event Scale: A Review. J Trauma Stress 2000, 13:101-13.
36. Horowitz MJ, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979, 41:209-18.
37. Brom D, Kleber RJ: De Schok Verwerkings Lijst. [Impact of Event Scale]. Ned Tijdschr Psychol 1985, 40:164-8.
38. Arrindell WA, Ettema JHM: Handleiding bij een multidimensionele psycho-pathologie indicator. [Manual for a multidimensional psycho-pathology indicator] Lisse: Swets & Zeitlinger; 1986.
39. Arrindell WA, Ettema JHM: Handleiding bij een multidimensionele psycho-pathologie indicator. [Manual for a multidimensional psycho-pathology indicator] Lisse: Swets & Zeitlinger; 2003.
40. Koeter MWJ, Ormel J: General Health Questionnaire: Nederlandse bewerking, handleiding. [Dutch version of manual] Lisse: Swets & Zeitlinger; 1991.
41. Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, Meer van der JWM, Bleijenberg G: Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994, 38:383-92.
42. Beurskens AJHM, Bultmann U, Kant I, Vercoulen JHMM, Bleijenberg G, Swaen MHG: Fatigue among working people: validity of a questionnaire measure. Occup Environ Med 2000, 57:353-7.
43. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey, Manual & Interpretation Guide Boston: Nimrod Press; 1997.
44. Aaronson NK, Muller M, Cohen PDA, Essink-Bot M, Fekkes M, Sanderman R, Sprangers MAG, Velde te A, Verrips E: Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations. J Clin Epidemiol 1998, 51:1055-68.
45. Leusden van HAIM: Diagnostisch Kompas: voorlichting over aanvullende diagnostiek [Diagnostic Compass: information on diagnostic tests] 3rd edition. Amstelveen: College voor zorgverzekeringen (CVZ); 2003.
46. Smeenk R, Van der Ley G, Aarden L: Measurements of low avidity anti-dsDNA by the crithidia luciliae test and the PEG assay. Clin Exp Immunol 1982, 49:603-10.
47. Faith A, Pontesilli O, Unger A, Panayi GS, John PJ: ELISA assays for IgM and IgG rheumatoid factors. Immunol Methods 1982, 55:169-77.
48. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 1989, 6:12-3.
49. Giessen van der M, Huiteman MG, Cohen Tervaert JW, Kallenberg CGM: A technical note on the routinely performed ANCA detection. APMIS 1989, 97:37.
50. Harris EN: Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990, 94:476-84.
51. Rupin A, Gruel Y, Watier H, Girard AC, Leroy J, Bardos PJ: ELISA for the detection of anticardiolipin antibodies. Immunol Methods 1991, 138:225-31.
52. Tresl I, Wannemacker de G, Quetel CR, Petrov I, Vanhaecke F, Moens L, Taylor PD: Validated measurements of the uranium isotopic signature in human urine samples using magnetic sector-field inductively coupled plasma mass spectrometry. Environ Sci Technol 2004, 38:581-6.
53. Cederblad G, Harper P, Lindgren K: Spectrophotometry of carnitine in biological fluids and tissue with a Cobas Bio centrifugal analyzer. Clin Chem 1986, 32:342-6.
54. Wan L, Hubbard RW: Determination of free and total carnitine with a random-access chemistry analyzer. Clin Chem 1998, 44:810-6.
55. Kuppeveld van FJ, Logt van der JT, Angulo AF, Zoest van MJ, Quint WG, Niesters HG, Galama JM, Melchers WJ: Genus- and species-specific identification of mycoplasmas bij 16S rRNA amplification. Appl Environ Microbiol 1992, 58:2606-15.
56. Blanchard A, Hamrick W, Duffy L, Baldus K, Cassell GH: Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid. Clin Infect Dis 1993, 17:S272-9.
57. Shalev AY, Tuval-Mashiach R, Hadar H: Posttraumatic stress disorder as a result of mass trauma. J Clin Psychiatry 2004, 65:4-10.
58. Pesatori AC, Consonni D, Bachetti S, Zocchetti C, Bonzini M, Baccarelli A, Bertazzi PA: Short- and long-term morbidity and mortality in the population exposed to dioxin after the "Seveso accident". Ind Health 2003, 41:127.
59. Dhara VR, Dhara R: The Union Carbide disaster in Bhopal: a review of health effects. Arch Environ Health 2002, 57:391-404.
60. Bard D, Verger P, Hubert P: Chernobyl, 10 years after: health consequences. Epidemiol Rev 1997, 19:187-204.
61. Gelpi E, Paz de la MP, Terracini B, Abaitua I, Camara de la AG, Kilbourne EM, Lahoz C, Nemery B, Philen RM, Soldevilla L, Tarkowski S: The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. Environ Health Perspect 2002, 110:457-64.
62. Collins DL: Human responses to the threat of or exposure to ionizing radiation at Three Mile Island, Pennsylvania, and Goiania, Brazil. Mil Med 2002, 167:137-8.
63. Havenaar JM, Cwikel JG, Bromet EJ: Toxic Turmoil. Psychological and Societal Consequences of Ecological Disasters New York: Kluwer Academic / Plenum Publishers; 2002.
64. Gray P: The Human Consequences of the Chernobyl Nuclear Accident. A strategy for Recovery, Chernobyl Report-Final-250102 edn 2002 [http:// www.undp.org/dpa/publications/chernobyl.pdf].
65. Foster K, Campbell D, Crum J, Stove M: Non-response in a population study after an environmental disaster. Public Health 1995, 109:267-73.
66. Logue JN, Melick ME, Hanssen H: Research issues and directions in the epidemiology of health effects of disasters. Epidemiol Rev 1981, 3:140-62.
67. Lechat MF: The epidemiology of health effects of disasters. Epidemiol Rev 1990, 12:192-8.
68. Dirkzwager AJ, Yzermans CJ, Kessels FJ: Psychological, musculoskeletal, and respiratory problems and sickness absence before and after involvement in a disaster: a longitudinal study among rescue workers. Occup Environ Med 2004, 61:870-2.
69. Alexander DA, Wells A: Reactions of police officers to bodyhandling after a major disaster. A before-and-after comparison. Br J Psychiatry 1991, 159:547-55.
70. Reijneveld SA, Crone MR, Verhulst FC, Verloove-Vanhorick SP: The effect of a severe disaster on the mental health of adolescents: a controlled study. Lancet 2003, 362:691-6.
71. Roht LH, Vernon SW, Weir FW, Pier SM, Sullivan P, Reed LJ: Community exposure to hazardous waste disposal sites: assessing reporting bias. Am J Epidemiol 1985, 122:418-33.
72. Kaye WE, Hall HI, Lybarger JA: Recall bias in disease status associated with perceived exposure to hazardous substances. Ann Epidemiol 1994, 4:393-7.
73. Hopwood DG, Guidotti TL: Recall Bias in Exposed Subjects Following a Toxic Exposure Incident. Arch Environ Health 1988, 43:234-7.
74. Lees-Haley PR, Brown RS: Biases in perception and reporting following a perceived toxic exposure. Percept Mot Skills 1992, 75:531-44.
75. Small GW, Borus JF: The influence of newspaper reports on outbreaks of mass hysteria. Psychiatr Q 1987, 58:269-78.
76. Vyner HM: The psychological dimensions of health care for patients exposed to radiation and the other invisible environmental contaminants. Soc Sci Med 1988, 27:1097-103.
77. Havenaar JM, Brink van den W: Psychological factors affecting health after toxicological disasters. Clin Psychol Rev 1997, 17:359-74.